|
 |
Allegra-DThis page contains recent news articles, when available, and an overview of Allegra-D but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Allegra-D (when available) Fexofenadine is a second-generation, long lasting H1-receptor antagonist (antihistamine) which has a selective and peripheral H1-antagonist action. Histamine is a chemical that causes many of the signs that are part of allergic reactions, for example, swelling of tissues. Histamine is released from histamine-storing cells (mast cells) and attaches to other cells that have receptors for histamine. The attachment of the histamine to the receptors causes the cell to be "activated," releasing other chemicals which produce the effects that we associate with allergy. Fexofenadine blocks one type of receptor for histamine (the H1 receptor) and thus prevents activation of cells by histamine. Unlike most other antihistamines, Fexofenadine does not enter the brain from the blood and, therefore, does not cause drowsiness. Fexofenadine lacks the cardiotoxic potential, since it does not block the potassium channel involved in repolarization of cardiac cells. For management of Seasonal allergic rhinitis Mechanism Of Action: Like other H1-blockers, Fexofenadine competes with free histamine for binding at H1-receptors in the GI tract, large blood vessels, and bronchial smooth muscle. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. Fexofenadine exhibits no anticholinergic, alpha1-adrenergic or beta-adrenergic-receptor blocking effects. News Articles on Fexofenadine Karate - Fotino Academy, argento per Antonio De Stefano - Dec 23, 2009 In rappresentanza della storica scuola avellinese, hanno partecipato ben 5 atleti: Allegra D'Alelio, Francesco Pio Santurelli, Antonio De Stefano, ... Irpinia News Teva Introduces Fexofenadine HCl and Pseudoephedrine HCl Extended-Release ... - Nov 3, 2009 ...the same as the sanofi-aventis US allergy treatment Allegra-D 12 Hour (fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg) Extended-Release Tablets. ... Reuters Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales ... - Nov 2, 2009 ALLEGRA-D and DRISDOL are registered trademarks of sanofi-aventis. About Prasco Prasco provides patients, pharmacists and customers with generic options ... Reuters Teva Releases Fexofenadine HCl and Pseudoephedrine HCl Extended-Release Tablets - Nov 5, 2009 ...the same as the sanofi-aventis US allergy treatment Allegra-D 12 Hour (fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg) Extended-Release Tablets. ... Trading Markets (press release) Teva rolls out antihistamine generic - Nov 4, 2009 The drug is a generic version of Sanofi-Aventis' Allegra-D and is designed to provide 12-hour relief from allergy symptoms. Allegra products had global ... Drug Store News (blog) טבע מחקה 49 מיליון דולר בגין בעיות ×?יכות במפעל ×”×•×•×˜×¨×™× ×¨×™×” ב×?רה"ב - Nov 4, 2009 ...טבע השיקה גרסה ×’× ×¨×™×ª של התרופה Allegra-D 12 Hoyr לטיפול ב×?לרגיות בשחרור מושהה. לפי × ×ª×•× ×™ ×¡×•×›× ×•×ª המחקר הרפו×?×™ IMS, מכירות המוצר ×‘×ž×•× ×—×™ תרופת המקור הגיעו ... The Marker Brand Names/Synonyms: Allegra-D is also known by the following brand names and/or synonymsAllegra; Allegra-D; CHEMBANK1622; Carboxyterfenadine; FEXOFENADINE HYDROCHLORIDE; Fexofenadine; Fexofendine; Terfenadine Acid Metabolite; Terfenadine Carboxylate; Terfenadine-Cooh Drug Category: Allegra-D is categorized under the following by the FDA: Antihistamines; Antihistamines; ATC:R06AX26 Dosage Forms: Oral tablets and capsules Absorption: 33% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 2-[4-[1-hydroxy-4-[4-(hydroxy-diphenyl-methyl)-1-piperidyl]-butyl]phenyl]-2-methyl-propanoicacid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
